Dermatologic findings in individuals with genetically confirmed Proteus syndrome
- PMID: 34105192
- PMCID: PMC8403137
- DOI: 10.1111/pde.14624
Dermatologic findings in individuals with genetically confirmed Proteus syndrome
Abstract
Background/objective: Proteus syndrome, caused by a mosaic activating AKT1 variant, typically presents in toddlers with progressive, asymmetric overgrowth of the skin and bones. We aimed to define the spectrum of dermatologic disease in individuals with genetically confirmed Proteus syndrome.
Methods: We conducted a retrospective review of records from dermatologic examinations of individuals evaluated at the NIH with a molecular diagnosis of Proteus syndrome. The types, prevalence, and localization of dermatologic findings were assessed.
Results: Fifty-one individuals (29 males, 22 females, mean age: 9 years) with clinical features of Proteus syndrome had the mosaic c.49G>A, p.Glu17Lys AKT1 variant. Fifty (98%) had at least one cutaneous feature constituting current clinical diagnostic criteria, including vascular malformations in 42 (82%), epidermal nevus in 41 (80%), volar cerebriform connective tissue nevi in 34 (67%), and adipose dysregulation in 30 (59%). Forty-nine (96%) had at least one dermatologic finding not included within the diagnostic criteria, including confluent volar skin-colored to hypopigmented papules or nodules (n = 33, 65%), papules or nodules on the digits or face (n = 27, 53%), and nonlinear epidermal nevi (n = 15, 29%). Other frequently observed features include nail changes (n = 28, 55%), hyperpigmented macules (n = 27, 53%), patchy dermal hypoplasia (n = 18, 35%), gingival/oral mucosal overgrowth (n = 17, 33%), hypopigmented macules (n = 16, 31%), dental enamel changes (n = 9, 18%), acrochordons (n = 6, 12%), and lingual overgrowth (n = 4, 8%).
Conclusions: The range of mucocutaneous features occurring in Proteus syndrome is broader than previously considered. These observations may assist in earlier diagnosis and management and provide novel insights regarding the pathogenesis of the condition.
Keywords: Genetic disease/mechanisms; genodermatoses; neoplasms-benign; skin signs of systemic disease; vascular malformations.
© Published 2021. This article is a U.S. Government work and is in the public domain in the USA.
Figures
Similar articles
-
Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes.Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4):a004036. doi: 10.1101/mcs.a004036. Print 2019 Aug. Cold Spring Harb Mol Case Stud. 2019. PMID: 31371346 Free PMC article.
-
Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.Am J Med Genet A. 2022 Sep;188(9):2766-2771. doi: 10.1002/ajmg.a.62761. Epub 2022 Apr 20. Am J Med Genet A. 2022. PMID: 35441778 Free PMC article.
-
Proteus syndrome review: molecular, clinical, and pathologic features.Clin Genet. 2014 Feb;85(2):111-9. doi: 10.1111/cge.12266. Epub 2013 Oct 23. Clin Genet. 2014. PMID: 23992099 Review.
-
Proteus Syndrome: Case Report with Anatomopathological Correlation.Fetal Pediatr Pathol. 2022 Oct;41(5):861-864. doi: 10.1080/15513815.2021.1989097. Epub 2021 Oct 20. Fetal Pediatr Pathol. 2022. PMID: 34668833
-
[A clinical study of Proteus syndrome caused by a mosaic somatic mutation in AKT1 gene].Zhonghua Nei Ke Za Zhi. 2019 Jul 1;58(7):508-513. doi: 10.3760/cma.j.issn.0578-1426.2019.07.005. Zhonghua Nei Ke Za Zhi. 2019. PMID: 31269567 Review. Chinese.
References
-
- Biesecker LG, Sapp JC. Proteus Syndrome. 2012August9 [Updated 2019 Jan 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK99495/. - PubMed
-
- Nguyen D, Turner JT, Olsen C, Biesecker LG, Darling TN. Cutaneous manifestations of proteus syndrome: correlations with general clinical severity. Arch Dermatol. 2004;140(8):947–953. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
